Try our beta test site
121 studies found for:    "Intraocular melanoma"
Show Display Options
Rank Status Study
1 Not yet recruiting Vorinostat in Patients With Class 2 High Risk Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: Vorinostat
2 Recruiting Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
Condition: Uveal Melanoma
Intervention:
3 Completed Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye
Condition: Intraocular Melanoma
Interventions: Genetic: fluorescence in situ hybridization;   Other: laboratory biomarker analysis;   Procedure: fine-needle aspiration;   Procedure: therapeutic conventional surgery;   Other: Questionnaires
4 Unknown  Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
Condition: Intraocular Melanoma
Interventions: Biological: bevacizumab;   Drug: temozolomide;   Genetic: polymorphism analysis;   Other: pharmacogenomic studies
5 Completed
Has Results
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
Condition: Intraocular Melanoma
Intervention: Drug: nab-paclitaxel
6 Completed New Biopsy Technique for Uveal Melanoma
Condition: Uveal Melanoma
Intervention:
7 Active, not recruiting Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
Condition: Uveal Melanoma
Intervention: Drug: AEB071
8 Recruiting Intermittent Selumetinib for Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: Selumetinib
9 Recruiting Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: Adjuvant chemotherapy by Fotemustin;   Other: Intensive surveillance
10 Recruiting Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis
Condition: Uveal Melanoma
Interventions: Procedure: SIRT;   Procedure: DSM-TACE
11 Recruiting A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.
Condition: Uveal Melanoma
Intervention: Drug: LXS196
12 Recruiting Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma
Condition: Uveal Melanoma, Monosomy 3 Positive, no Evidence for Metastases.
Intervention: Biological: Autologous Dendritic Cells loaded with autologous Tumor RNA
13 Terminated Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Condition: Uveal Melanoma
Intervention: Biological: autologous dendritic cells electroporated with mRNA
14 Completed
Has Results
Treatment With Intravitreal Avastin for Large Uveal Melanomas
Condition: Uveal Melanoma
Intervention: Drug: AVASTIN
15 Recruiting Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Condition: Uveal Melanoma
Intervention: Drug: Crizotinib
16 Unknown  Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: CP-675,206
17 Unknown  Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Procedure: Intraoperative ultrasonography
18 Recruiting Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Radiation: Hypofractionated linear accelerator radiotherapy
19 Completed RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: RAD001 (Everolimus) and Pasireotide (SOM230) LAR
20 Active, not recruiting A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: Placebo;   Drug: Sorafenib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.